SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-19-004882
Filing Date
2019-02-27
Accepted
2019-02-27 16:02:21
Documents
64
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K abio-10k_20181231.htm 10-K 2402653
2 EX-23.1 abio-ex231_8.htm EX-23.1 3779
3 EX-31.1 abio-ex311_9.htm EX-31.1 14996
4 EX-31.2 abio-ex312_6.htm EX-31.2 16106
5 EX-32.1 abio-ex321_7.htm EX-32.1 9350
6 GRAPHIC g120gpcy2axt000001.jpg GRAPHIC 8549
  Complete submission text file 0001564590-19-004882.txt   6703215

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT abio-20181231.xml EX-101.INS 1211994
8 XBRL TAXONOMY EXTENSION SCHEMA abio-20181231.xsd EX-101.SCH 43991
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20181231_cal.xml EX-101.CAL 40437
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20181231_def.xml EX-101.DEF 142258
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20181231_lab.xml EX-101.LAB 395843
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20181231_pre.xml EX-101.PRE 291038
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22873 | Film No.: 19637605
SIC: 2835 In Vitro & In Vivo Diagnostic Substances